State Street Corp Hutchmed (China) LTD Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Hutchmed (China) LTD stock. As of the latest transaction made, State Street Corp holds 328,792 shares of HCM stock, worth $5.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
328,792
Previous 336,865
2.4%
Holding current value
$5.04 Million
Previous $5.07 Million
2.33%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding HCM
# of Institutions
62Shares Held
6.07MCall Options Held
0Put Options Held
0-
Schroder Investment Management Group London, X02.58MShares$39.6 Million0.03% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M925KShares$14.2 Million0.02% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.84 Million0.11% of portfolio
-
Goldman Sachs Group Inc New York, NY289KShares$4.44 Million0.0% of portfolio
-
M&G PLC London, X0260KShares$3.98 Million0.02% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.65B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...